WCM
EW icon

Weaver Capital Management’s Edwards Lifesciences EW Stock Holding History

Weaver Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$703K Sell
8,773
-976
-10% -$80.5K 0.15% 115
2025
Q4 		$831K Sell
9,749
-97
-1% -$7.96K 0.18% 114
2025
Q3 		$766K Sell
9,846
-747
-7% -$58.4K 0.17% 111
2025
Q2 		$828K Sell
10,593
-205
-2% -$15.3K 0.2% 107
2025
Q1 		$783K Buy
10,798
+110
+1% +$7.87K 0.21% 106
2024
Q4 		$791K Buy
10,688
+5,560
+108% +$389K 0.22% 108
2024
Q3 		$338K Sell
5,128
-5,525
-52% -$401K 0.1% 139
2024
Q2 		$984K Sell
10,653
-155
-1% -$13.7K 0.32% 84
2024
Q1 		$1.03M Buy
10,808
+2,890
+36% +$243K 0.35% 80
2023
Q4 		$604K Buy
+7,918
New +$551K 0.24% 90

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Weaver Capital Management's EW Position: Q1 2026 in Review

Weaver Capital Management reduced its Edwards Lifesciences (EW) stake by 10% in Q1 2026, selling an estimated $80.5K and leaving 8,773 shares worth $703K. The position accounts for 0.15% of the portfolio, ranked #115.

Weaver Capital Management first reported a position in EW in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.03M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Weaver Capital Management held 8,773 shares of Edwards Lifesciences worth $703K as of Q1 2026.
  • Weaver Capital Management sold 976 Edwards Lifesciences shares in Q1 2026, an estimated $80.5K.
  • Edwards Lifesciences made up 0.15% of Weaver Capital Management's portfolio in Q1 2026, its #115 holding.
  • Weaver Capital Management first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 10 quarters since.
  • Weaver Capital Management's Edwards Lifesciences position peaked at $1.03M in Q1 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Weaver Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.